TP53 and cancer: Collectively, SNCP8 not only served as a nanoreactor to make conformation of p53pep more stable but also served as a peptide carrier to deliver st-p53pep to tumor tissues and cancer cells, sustainably releasing the cargo and effectively inducing p53-mediated apoptosis in vivo.